Ethical issues in studying the safety of approved drugs : a letter report /

Saved in:

Bibliographic Details
Corporate author / creator:	Institute of Medicine (U.S.). Committee on Ethical and Scientific Issues in Studying the Safety of Approved Drugs, author.
Imprint:	Washington, D.C. : National Academies Press, [2010]
Description:	1 online resource (1 PDF file (viii, 15 pages))
Language:	English
Subject:	Drugs -- United States -- Testing. Clinical trials -- Moral and ethical aspects. Informed consent (Medical law) -- Moral and ethical aspects -- United States. Human experimentation in medicine -- Government policy -- United States. Clinical Trials as Topic -- ethics. Product Surveillance, Postmarketing. Informed Consent -- ethics. Clinical trials -- Moral and ethical aspects. Drugs -- Testing. Human experimentation in medicine -- Government policy. Informed consent (Medical law) -- Moral and ethical aspects. United States. United States.
Format:	E-Resource Book
URL for this record:	http://pi.lib.uchicago.edu/1001/cat/bib/11226278

Hidden Bibliographic Details
ISBN:	9780309157780 0309157781
Notes:	Title from PDF title page. Includes bibliographical references. This study was supported by contract HHSF223200810020I between the National Academy of Sciences and the Food and Drug Administration. Any opinions, findings, conclusions, or recommendations expressed in this publication are those of the authors and do not necessarily reflect the view of the organizations or agencies that provided support for this project. Version viewed Mar. 18, 2015.
Summary:	The FDA requested that the IOM examine the ethical and informed consent issues that should be considered when conducting clinical trials to evaluate drug safety. This report outlines when and how the FDA should conduct clinical trials to protect the public's health and the health of trial participants.

Similar Items